PRC medical instruments company in H-share placement
June 01, 2011 | BY
clpstaff &clp articlesPRC medical products supplier Shandong Weigao Medical Polymer Company has raised HK$1.8 billion (US$227 million) in connection with its placement of new…
PRC medical products supplier Shandong Weigao Medical Polymer Company has raised HK$1.8 billion (US$227 million) in connection with its placement of new H-shares. The proceeds will be used to build a new production plant.
The joint global coordinators, joint bookrunners and joint placing agents were China International Capital Corporation and Morgan Stanley.
Acting for the Hong Kong-listed issuer was a Troutman Sanders Hong Kong team led by Shirley Lau and Joe Sevack.
The underwriters were advised by Slaughter and May on Hong Kong Law and Davis Polk & Wardwell on US law.
This premium content is reserved for
China Law & Practice Subscribers.
A Premium Subscription Provides:
- A database of over 3,000 essential documents including key PRC legislation translated into English
- A choice of newsletters to alert you to changes affecting your business including sector specific updates
- Premium access to the mobile optimized site for timely analysis that guides you through China's ever-changing business environment
Already a subscriber? Log In Now